Most Recent

image: $230M for Big Disease

$230M for Big Disease

By | February 5, 2014

The National Institutes of Health is partnering with 10 drug companies to find new treatments for Alzheimer’s disease, diabetes, rheumatoid arthritis, and lupus.

1 Comment

image: New Bird Flu Threat?

New Bird Flu Threat?

By | February 4, 2014

Chinese officials report the first two human cases of H10N8 avian influenza, one of which is linked to the death of a 73-year-old woman.

0 Comments

image: Microbial Smog

Microbial Smog

By | February 3, 2014

Some 1,300 species of microbes, including some associated with allergies and lung disease, are adrift in Beijing’s thick smog.

4 Comments

image: An Offensive Playbook

An Offensive Playbook

By | February 1, 2014

Developing nonaddictive drugs to combat pain

0 Comments

image: Book Excerpt from <em>Buddhist Biology</em>

Book Excerpt from Buddhist Biology

By | February 1, 2014

In Chapter 1, “A Science Sutra,” author David Barash describes how the ancient philosophy might form the perfect link between science and religion.

11 Comments

image: Contributors

Contributors

By | February 1, 2014

Meet some of the people featured in the February 2014 issue of The Scientist.

0 Comments

image: On Race and Medicine

On Race and Medicine

By | February 1, 2014

Until health care becomes truly personalized, race and ethnicity will continue to be important clues guiding medical treatments.

2 Comments

image: Self-Improvement Through the Ages

Self-Improvement Through the Ages

By | February 1, 2014

A 50,000-generation-long experiment shows that bacteria keep getting fitter.

2 Comments

image: Pain and Progress

Pain and Progress

By | February 1, 2014

Is it possible to make a nonaddictive opioid painkiller?

1 Comment

image: Syphilis: Then and Now

Syphilis: Then and Now

By , , and | February 1, 2014

Researchers are zeroing in on the origin of syphilis and related diseases, which continue to plague the human population some 500 years after the first documented case.

12 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS